Cargando...
Proteomics and peptidomics: moving toward precision medicine in urological malignancies
Urological malignancies are a major cause of morbidity and mortality worldwide. Advances in early detection, diagnosis, prognosis and prediction of treatment response can significantly improve patient care. Proteomic and peptidomic profiling studies are at the centre of kidney, prostate and bladder...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5239567/ https://ncbi.nlm.nih.gov/pubmed/27119500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8931 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|